Roche in Basel is seeking a diligent Research Associate to join the non-malignant hematology group within pRED CM I2. You will design and execute in vitro and ex vivo experiments to evaluate novel therapies for bleeding disorders such as hemophilia and von Willebrand disease.
You will validate novel systems, apply confocal imaging, and collaborate closely with the team to interpret data and optimize test platforms for efficacy and safety assessments.
#J-18808-Ljbffr
